 Fludarabine new agent marked cytoreductive activity untreated chronic lymphocytic leukemia Thirty-three patients chronic lymphocytic leukemia CLL advanced Rai stage III-IV progressive Rai stage disease fludarabine single agent Eleven patients complete remission CR clinical CR residual nodules evidence disease nodular partial remission PR patients PR total response rate Response rapid courses treatment major morbidity infection Febrile courses minor infection transient fever undocumented cause Fludarabine cytoreductive single agent CLL